Medlive Technology Co

Medlive Technology Co Gross Margin

The Gross Margin of Medlive Technology Co (2192.HK) as of Nov 1, 2026 is 60.02 %. In the previous year, Gross Margin was 58.59 % — a change of 2.44% (higher).

Gross Margin

60.02 %

YoY

2.44%

Last updated:

Gross Margin of Medlive Technology Co is 2025 60.02 % . Gross Margin of Medlive Technology Co was 2024 58.59 % . It decreases by 2.44% higher compared to the previous year.

Medlive Technology Co's gross margin stands at 60.0%, down from 70.6% several years earlier.

The Medlive Technology Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
59.77 CNY
Jan 1, 2019
63.49 CNY
Jan 1, 2020
73.17 CNY
Jan 1, 2021
70.57 CNY
Jan 1, 2022
67.74 CNY
Jan 1, 2023
61.00 CNY
Jan 1, 2024
58.59 CNY
Jan 1, 2025
60.02 CNY
The Medlive Technology Co Gross Margin history
YEARGross MarginYoY
60.02 %+2.44%
58.59 %-3.95%
61.00 %-9.95%
67.74 %-4.01%
70.57 %-3.55%
73.17 %+15.24%
63.49 %+6.22%
59.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medlive Technology Co Stock analysis

What does Medlive Technology Co do? Medlive Technology Co., Ltd. generates revenue through three core segments. Its Precision Marketing and Corporate Solutions segment offers digital detailing, digital marketing consulting, and digital content creation services, while corporate solutions primarily deliver software as a service (SaaS). The Medical Knowledge Solutions segment provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment focuses on online patient consultation, prescription services, and patient management services. All services are provided within the domestic market. The company's primary customers include businesses seeking precision marketing services, healthcare organizations requiring medical knowledge solutions, and patients utilizing online consultation platforms. Corporate clients purchase SaaS-based corporate solutions, while healthcare providers and patients engage with medical information and patient management services. Revenue streams are derived from these distinct service offerings across the three business segments. Medlive Technology Co., Ltd. operates exclusively within the domestic market, serving clients through its three established business segments. The firm's revenue model relies on delivering specialized digital and medical services tailored to corporate, healthcare, and patient needs. All service offerings are designed to address specific market demands within China's domestic market. Medlive Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medlive Technology Co stock

Gross Margin of Medlive Technology Co is 60.02 % in 2025.

Gross Margin of Medlive Technology Co changed from 58.59 % to 60.02 %, representing a 2.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Medlive Technology Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Medlive Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Medlive Technology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Medlive Technology Co